Health

Blood Pressure Drug Reduces Risk Of Cardiovascular Disease and Stroke


According to a press release by the AHA, a new study published in Hypertension: Journal of the American Heart Association has shown that a long-acting ACE inhibitor used to reduce blood pressure significantly decreased the risk for cardiovascular disease, including stroke, in normal weight, overweight and obese patients.  Obese...



Increase in Diabetes and Obesity Linked to Sugary Drinks


A new study, reported by the American Heart Association, estimates that the increased consumption of sugar-sweetened beverages between 1990 and 2000 contributed to 130,000 new cases of diabetes. Sugar-sweetened soda, sport and fruit drinks (not 100 percent fruit juice) contain equivalent calories, ranging from 120 to 200 per drink,...



FDA Tells Food Companies to Correct Labeling Violations


The U.S. Food and Drug Administration (FDA) has notified 17 food manufacturers that the labeling for 22 of their food products violates the Federal regulations. The action follows an October 2009 statement by Commissioner of Food and Drugs, Margaret Hamburg, M.D., encouraging companies to review their labeling to ensure that they...



Childhood Obesity Prevention Should Begin Much Earlier


A new study published in the online version of the journal Pediatrics, found that efforts to prevent childhood obesity should begin far earlier than currently thought, perhaps even before birth. The study, reported by EurekAlert, tracked 1,826 women,  (1,343 white, 355 black and 128 Hispanic) from pregnancy through their children’s...



Stroke Among Young People on the Rise


According to a new study from the University of Cincinnati Neuroscience Institute, over the past few years, the number of strokes among younger Americans is on the rise while among older American the numbers have declined. According to the report in Business Week, the study found that while doctors are getting a handle on the problem...



Amylin and Takeda Advance Development of New Obesity Treatment


Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study results in a new obesity treatment, they will  advance towards phase 3 development of a combination treatment for obesity which includes pramlintide (an analog of the natural hormone amylin)  and metreleptin  (an...



IOM Report Declares High Blood Pressure a Neglected Disease


According to a new report by the Institute Of Medicine, high blood pressure is a neglected disease in the United States.  The report calls for strategies to change Americans’ lifestyles and diets to curb hypertension. High blood pressure or hypertension is easily preventable through diet, exercise and drugs, yet it is the second-leading...



Obesity on the Rise in the UK


Telegraph reports 8 in 10 men and nearly 7 in 10 women in the UK will be overweight or obese by 2020.  According to a new study, an update of the Government-commissioned Foresight report, released in 2007, there is no basis for hope that the obesity crisis is easing.  Moreover, the study predicts that cases of diabetes related...



Coke, Pepsi to Implement Better Calorie Labeling


Last October, Muhtar Kent, CEO of the Coca-Cola Company wrote an article in the Wall Street Journal, “Coke Didn’t Make America Fat,” where he argued that sodas should not be taxed because sedentary lifestyle should be blamed for obesity in America – not Coke.  Now, after the announcement of  a new initiative...



Women Taking Common Type 2 Diabetes Drug at Higher Risk for Fractures


A new study published in The Journal of Clinical Endocrinology & Metabolism has found that women with type 2 diabetes who take a commonly prescribed class of medications to treat insulin resistance may be at a higher risk for developing bone fractures. The study conducted at Henry Ford Hospital in Detroit, and reported by EurekAlert...



Page 1 of 41234

Subscribe
to our
newsletter

advertisement
advertisement
  • Popular
  • Latest
  • Comments
  • Tags
  • Subscribe